List of articles with "AP-SA02"

Armata Q3 2025 Update

Armata Q3 2025 Update

United States Los Angeles Armata Pharmaceuticals AP-SA02 bacteriophage
Positive Data from AP-SA02

Positive Data from AP-SA02

United States Atlanta Armata Pharmaceuticals AP-SA02 IDWeek 2025
Armata at IDWeek 2025

Armata at IDWeek 2025

United States Atlanta Armata Pharmaceuticals Bacteriophage Therapy AP-SA02
Armata's Q2 2025 Highlights

Armata's Q2 2025 Highlights

United States Los Angeles Armata Pharmaceuticals AP-SA02 bacteriophage
Armata's Phage Therapy Study

Armata's Phage Therapy Study

USA Los Angeles Armata Pharmaceuticals AP-SA02 diSArm Study
Armata Q1 2025 Results

Armata Q1 2025 Results

USA Los Angeles biotechnology Armata Pharmaceuticals AP-SA02
Armata Gains $4.65M Funding

Armata Gains $4.65M Funding

USA Los Angeles Armata Pharmaceuticals AP-SA02 diSArm Trial

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.